References
- Muñoz A, Schrager LK, Bacellar H, et al. Trends in the incidence of outcomes defining acquired immunodeficiency syndrome (AIDS) in the Multicenter AIDS Cohort Study: 1985–1991. Am J Epidemiol 1993; 137(4): 423–38
- Pitkin AD, Grant AD, Foley NM, et al. Changing patterns of respiratory disease in HIV positive patients in a referral centre in the United Kingdom between 1986–7 and 1990–1. Thorax 1993; 48(3): 204–7
- Hughes W, Leoung G, Kramer F, et al. Comparison of atovaquone (566C80) with trimethoprim-sulfamethoxawle to treat Pneumocystis carinii pneumonia in patients with AIDS. N Engl J Med 1993; 328(21): 1521–7
- Centers for Disease Control. Recommendations for prophylaxis against Pneumocystis carinii pneumonia for adults and adolescents infected with human immunodeficiency virus. MMWR 1992; 41(RR-4): 1–11
- Centers for Disease Control. Guidelines for prophylaxis against Pneumocystis carinii pneumonia for children infected with human immunodeficiency virus. MMWR 1991; 40 (RR-2): 1–13
- Girard PM, Landman R, Gaudebout C, et al. Dapsone-pyrimethamine compared with aerosolized pentamidine as primary prophylaxis against Pneumocystis carinii pneumonia and toxoplasmosis in HIV infection. N Engl J Med 1993; 328(21): 1514–20
- Carr A, Tindall B, Brew BJ, et al. low-dose trimethoprim-sulfamethoxazole prophylaxis for toxoplasmic encephalitis in patients with AIDS. Ann Intern Med 1992; 117(2): 106–11
- Nightingale SD, Cameron DW, Gordin FM, et al. Two controlled trials of rifubutin prophylaxis against Mycobacterium avium complex infection in AIDS. N Engl J Med 1993; 329(12): 828–33
- Masur H. Recommendations on prophylaxis and therapy for disseminated Mycobacterium avium complex disease in patients infected with the human immunodeficiency virus. N Eng! J Med 1993; 329(12): 898–904
- Iseman MD. Treatment of multidrug-resistant tuberculosis. N Engl J Med 1993; 329(11): 784–91